CELEX: 
Language: en
Date: 2020-05-19 00:00:00
Title: COMMISSION DELEGATED REGULATION (EU) …/... amending, for the purposes of its adaptation to technical and scientific progress, Part 3 of Annex VI to Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures

EUROPEAN
                             COMMISSION
                                                       Brussels, 19.5.2020
                                                       C(2020) 3151 final
                 COMMISSION DELEGATED REGULATION (EU) …/...
                                           of 19.5.2020
   amending, for the purposes of its adaptation to technical and scientific progress, Part 3
    of Annex VI to Regulation (EC) No 1272/2008 of the European Parliament and of the
        Council on classification, labelling and packaging of substances and mixtures
                                   (Text with EEA relevance)
EN                                                                                           EN
 ---pagebreak---                                   EXPLANATORY MEMORANDUM
   1.        CONTEXT OF THE DELEGATED ACT
   The objectives of Regulation (EC) No 1272/2008 on classification, labelling and packaging of
   substances and mixtures (CLP) are to ensure a high level of protection of human health and
   the environment as well as the free movement of substances, mixtures and articles. These
   objectives are fulfilled, inter alia, by establishing a list of substances with their harmonised
   classifications and labelling elements at Union level. Article 37(5) of Regulation (EC)
   No 1272/2008 empowers the Commission to include, without undue delay, substances in
   Table 3 of Part 3 of Annex VI, where it finds that the harmonisation of the classification and
   labelling is appropriate (Table 3.1 has been renamed Table 3 since the deletion of Table 3.2).
   Based on the opinions issued by the Committee for Risk Assessment (RAC) of the European
   Chemicals Agency (ECHA), as well as on the comments received from the parties concerned,
   it is appropriate to introduce, update, delete or leave unchanged the harmonised classification
   and labelling of certain substances and amend Table 3 of Part 3 of Annex VI to Regulation
   (EC) No 1272/2008 accordingly.
   2.        CONSULTATIONS PRIOR TO THE ADOPTION OF THE ACT
   In accordance with Article 37(4) of Regulation (EC) No 1272/2008, ECHA has performed a
   public consultation for each substance to be included, modified or deleted in Table 3 of Part 3
   of Annex VI, before the adoption of the respective opinion on the proposals for harmonised
   classification and labelling by its Committee for Risk Assessment (RAC). The comments
   provided in the course of the public consultations have been taken into account by RAC.
   Pursuant to Article 53a(4) of Regulation (EC) No 1272/2008, experts designated by each
   Member State were consulted in the relevant expert group CARACAL (Competent authorities
   for REACH and CLP). In accordance with point 10 of the Annex to the Interinstitutional
   Agreement on Better Law-Making of 13 April 20161 the European Parliament and the
   Council have been invited to participate in the CARACAL expert group.
   Stakeholders were consulted in the CARACAL expert group in accordance with point 6 of the
   Annex to that agreement.
   3.        LEGAL ELEMENTS OF THE DELEGATED ACT
   The legal act amends Regulation (EC) No 1272/2008. The legal basis of this delegated act is
   Article 37(5) of Regulation (EC) No 1272/2008.
   1
            OJ L 123 of 12.05 2016, p. 1.
EN                                                  1                                               EN
 ---pagebreak---                      COMMISSION DELEGATED REGULATION (EU) …/...
                                                of 19.5.2020
     amending, for the purposes of its adaptation to technical and scientific progress, Part 3
      of Annex VI to Regulation (EC) No 1272/2008 of the European Parliament and of the
          Council on classification, labelling and packaging of substances and mixtures
                                        (Text with EEA relevance)
   THE EUROPEAN COMMISSION,
   Having regard to the Treaty on the Functioning of the European Union,
   Having regard to Regulation (EC) No 1272/2008 of the European Parliament and of the
   Council of 16 December 2008 on classification, labelling and packaging of substances and
   mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending
   Regulation (EC) No 1907/20062, and in particular Article 37(5) thereof,
   Whereas:
   (1)     Table 3 of Part 3 of Annex VI to Regulation (EC) No 1272/2008 contains the list of
           harmonised classification and labelling of hazardous substances based on the criteria
           set out in Parts 2 to 5 of Annex I to that Regulation.
   (2)     Proposals to introduce harmonised classification and labelling of certain substances
           and to update or delete the harmonised classification and labelling of certain other
           substances have been submitted to the European Chemicals Agency (‘Agency’)
           pursuant to Article 37 of Regulation (EC) No 1272/2008. Based on the opinions3 on
           those proposals issued by the Committee for Risk Assessment of the Agency (RAC),
           as well as on the comments received from the parties concerned, it is appropriate to
           introduce, update or delete the harmonised classification and labelling of certain
           substances. Those RAC opinions are:
             –      Opinion of 8 June 2018 concerning nitric acid ... %[C ≤70%];
             –      Opinion of 9 March 2018 concerning silicon carbide fibres (with diameter < 3
                    µm, length > 5 µm and aspect ratio ≥ 3:1);
             –      Opinion of 8 June 2018 concerning trimethoxyvinylsilane;
                    trimethoxy(vinyl)silane;
   2
           OJ L 353, 31.12.2008, p. 1
   3
           The opinions are accessible via the following website: https://echa.europa.eu/registry-of-clh-
           intentions-until-outcome/-/dislist/name/-/ecNumber/-/casNumber/-/dte_receiptFrom/-
           /dte_receiptTo/-/prc_public_status/Opinion+Adopted/dte_withdrawnFrom/-
           /dte_withdrawnTo/-/sbm_expected_submissionFrom/-/sbm_expected_submissionTo/-
           /dte_finalise_deadlineFrom/-/dte_finalise_deadlineTo/-/haz_addional_hazard/-/lec_submitter/-
           /dte_assessmentFrom/-/dte_assessmentTo/-/prc_regulatory_programme/-/
EN                                                    2                                                   EN
 ---pagebreak---    – Opinion of 8 June 2018 concerning tris(2-methoxyethoxy)vinylsilane; 6-(2-
     methoxyethoxy)-6-vinyl-2,5,7,10-tetraoxa-6-silaundecane;
   – Opinion of 8 June 2018 concerning dimethyl disulphide;
   – Opinion of 8 June 2018 concerning granulated copper;
   – Opinion of 30 November 2018 concerning bis(N-hydroxy-N-
     nitrosocyclohexylaminato-O,O')copper; bis(N-cyclohexyl-diazenium-dioxy)-
     copper; [Cu-HDO];
   – Opinion of 14 September 2018 concerning dioctyltin dilaurate; [1] stannane,
     dioctyl-, bis(coco acyloxy) derivs. [2];
   – Opinion of 30 November             2018   concerning   dibenzo[def,p]chrysene;
     dibenzo[a,l]pyrene;
   – Opinion      of    9    March      2018     concerning     ipconazole   (ISO);
     (1RS,2SR,5RS;1RS,2SR,5SR)-2-(4-chlorobenzyl)-5-isopropyl-1-(1H-1,2,4-
     triazol-1-ylmethyl)cyclopentanol;
   – Opinion of 8 June 2018 concerning bis(2-(2-methoxyethoxy)ethyl)ether;
     tetraglyme;
   – Opinion of 8 June 2018 concerning paclobutrazol (ISO); (2RS,3RS)-1-(4-
     chlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pentan-3-ol;
   – Opinion of 8 June 2018 concerning 2,2-bis(bromomethyl)propane-1,3-diol;
   – Opinion of 14 September 2018 concerning geraniol; (2E)-3,7-dimethylocta-
     2,6-dien-1-ol;
   – Opinion of 28 January 2019 concerning 2-(4-tert-
     butylbenzyl)propionaldehyde;
   – Opinion of 9 March 2018 concerning MCPA-thioethyl (ISO); S-ethyl (4-
     chloro-2-methylphenoxy)ethanethioate; S-ethyl 4-chloro-o-tolyloxythioacetate;
   – Opinion of 9 March 2018 concerning diisooctyl phthalate;
   – Opinion of 14 September 2018 concerning 4-{[(6-chloropyridin-3-
     yl)methyl](2,2-difluoroethyl) amino}furan-2(5H)-one; flupyradifurone;
   – Opinion of 30 November 2018 concerning thiencarbazone-methyl (ISO);
     methyl 4- [(4,5-dihydro-3-methoxy-4-methyl-5-oxo-1H-1,2,4-triazol-1-
     yl)carbonylsulfamoyl]-5-methylthiophene-3-carboxylate;
   – Opinion of 9 March           2018     concerning   L-(+)-lactic  acid; (2S)-2-
     hydroxypropanoic acid;
   – Opinion of 9 March 2018 concerning 2-methoxyethyl acrylate;
   – Opinion of 8 June 2018 concerning glyoxylic acid …%;
   – Opinion of 14 September 2018 concerning sodium N-
     (hydroxymethyl)glycinate; [formaldehyde released from sodium N-
     (hydroxymethyl)glycinate];
   – Opinion of 30 November 2018 concerning potassium (oxido-NNO-
     azoxy)cyclohexane; cyclohexylhydroxydiazene 1-oxide, potassium salt; [K-
     HDO];
EN                                   3                                              EN
 ---pagebreak---    – Opinion of 14 September 2018 concerning mecetronium etilsulfate; N-ethyl-
     N,N-dimethylhexadecan-1-aminium ethyl sulfate; mecetronium ethyl sulphate
     [MES];
   – Opinion of 9 March 2018 concerning (2RS)-2-[4-(4-chlorophenoxy)-2-
     (trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol;
     mefentrifluconazole;
   – Opinion of 30 November 2018 concerning oxathiapiprolin (ISO); 1-(4-{4-[5-
     (2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-
     1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone;
   – Opinion of 14 September 2018 concerning pyrithione zinc;           (T-4)-bis[1-
     (hydroxy-.kappa.O) pyridine-2(1H)-thionato-.kappa.S]zinc;
   – Opinion of 30 November 2018 concerning 3-chloro-4-(chloromethyl)-1-[3-
     trifluoromethyl)phenyl]pyrrolidin-2-one; flurochloridone (ISO);
   – Opinion of 30 November 2018 concerning 4,5-dichloro-2-octyl-2H-isothiazol-
     3-one; [DCOIT];
   – Opinion of 8 June 2018 concerning 2-methyl-1,2-benzothiazol-3(2H)-one;
     [MBIT];
   – Opinion of 30 November 2018 concerning 3-(difluoromethyl)-1-methyl-N-
     (3',4',5'-trifluorobiphenyl-2-yl)pyrazole-4-carboxamide; fluxapyroxad;
   – Opinion of 8 June 2018               concerning   N-(hydroxymethyl)acrylamide;
     methylolacrylamide; [NMA];
   – Opinion of 15 October 2018 concerning 5-fluoro-1,3-dimethyl-N-[2-(4-
     methylpentan-2-yl)phenyl]-1H-pyrazole-4-carboxamide; 2’-[(RS)-1,3-
     dimethylbutyl]-5-fluoro-1,3-dimethylpyrazole-4-carboxanilide; penflufen;
   – Opinion of 30 November 2018 concerning iprovalicarb(ISO); isopropyl [(2S)-
     3-methyl-1-{[1-(4-methylphenyl)ethyl]amino}-1-oxobutan-2-yl]carbamate ;
   – Opinion of 30 November 2018 concerning silthiofam (ISO); N-allyl-4,5-
     dimethyl-2-(trimethylsilyl)thiophene-3-carboxamide;
   – Opinion of 9 March 2018 concerning Margosa, ext. [cold-pressed oil of
     Azadirachta indica seeds without shells extracted with super-critical carbon
     dioxide];
   – Opinion of 8 June 2018 concerning nitric acid …%[C> 70%];
   – Opinion of 9 March 2018 concerning octamethylcyclotetrasiloxane; [D4];
   – Opinion of 30 November 2018 concerning pirimiphos-methyl (ISO); O-[2-
     (diethylamino)-6-methylpyrimidin-4-yl] O,O-dimethyl phosphorothioate;
   – Opinion of 30 November 2018 concerning phosphine;
   – Opinion of 14 September 2018 concerning dichlorodioctylstannane;
   – Opinion of 30 November 2018 concerning 2-ethylhexyl 10-ethyl-4,4-dioctyl-7-
     oxo-8-oxa-3,5-dithia-4-stannatetradecanoate; [DOTE];
   – Opinion of 30 November 2018 concerning lead;
   – Opinion of 14 September 2018 concerning 2-butoxyethanol; ethylene glycol
     monobutyl ether;
EN                                     4                                             EN
 ---pagebreak---          –     Opinion of 30 November 2018 concerning m-bis(2,3-epoxypropoxy)benzene;
               resorcinol diglycidyl ether;
         –     Opinion of 14 September 2018 concerning tribenuron-methyl (ISO); methyl 2-
               [N-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-N-
               methylcarbamoylsulfamoyl]benzoate;
         –     Opinion of 8 June 2018 concerning azoxystrobin (ISO); methyl (E)-2-{2-[6-(2-
               cyanophenoxy)pyrimidin-4-yloxy]phenyl}-3-methoxyacrylate;
         –     Opinion of 9 March 2018 concerning ethofumesate (ISO); (RS)-2-ethoxy-2,3-
               dihydro-3,3-dimethylbenzofuran-5-yl methanesulfonate;
         –     Opinion of 30 November 2018 concerning 2,4-dinitrophenol;
         –     Opinion of 14 September 2018 concerning mesotrione (ISO); 2-[4-
               (methylsulfonyl)-2-nitrobenzoyl]-1,3-cyclohexanedione;
         –     Opinion of 30 November 2018 concerning octhilinone (ISO); 2-octyl-2H-
               isothiazol-3-one; [OIT];
         –     Opinion of 14 September 2018 concerning hymexazol (ISO); 3-hydroxy-5-
               methylisoxazole;
         –     Opinion of 30 November 2018 concerning hexythiazox (ISO); trans-5-(4-
               chlorophenyl)-N-cyclohexyl-4-methyl-2-oxo-3-thiazolidine-carboxamide;
         –     Opinion of 9 March 2018 concerning pymetrozine (ISO); (E)-4,5-dihydro-6-
               methyl-4-(3-pyridylmethylene amino)-1,2,4-triazin-3(2H)-one;
         –     Opinion of 9 March 2018 concerning imiprothrin (ISO); reaction mass of: [2,4-
               dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-cis-chrysanthemate; [2,4-
               dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-trans-chrysanthemate;
         –     Opinion of 14 September 2018 concerning butanone oxime; ethyl methyl
               ketoxime; ethyl methyl ketone oxime;
         –     Opinion of 8 June 2018 concerning bis(α,α-dimethylbenzyl) peroxide;
         –     Opinion of 9 March 2018 concerning branched hexatriacontane;
         –     Opinion of 30 November 2018 concerning hexyl 2-(1-
               (diethylaminohydroxyphenyl) methanoyl)benzoate; hexyl 2-[4-(diethylamino)-
               2-hydroxybenzoyl]benzoate.
   (3) With regard to the substance lead (CAS number 7439-92-1 and index numbers 082-
       013-00-1 (lead powder; [particle diameter < 1mm];) and 082-014-00-7 (lead massive;
       [particle diameter ≥ 1mm];)), RAC proposed in its opinion of 30 November 2018 to
       apply the same environmental classification to the massive and the powder form.
       However, in view of the lower dissolution rate of the massive form, the malleable
       structure of lead, the specific intentional production of the powder and the different
       environmental classification between massive and powder forms for existing entries in
       Annex VI for other metals, further assessment needs to be done by RAC on whether to
       apply the same environmental classification to the massive as to the powder form of
       lead. In addition, new scientific data has been made available suggesting that the
       environmental classification for the massive form as recommended in the RAC
       opinion might not be appropriate Therefore, the environmental classification for the
EN                                             5                                              EN
 ---pagebreak---           massive form will not be included in Annex VI to Regulation (EC) No 1272/2008 until
          RAC has had the opportunity to deliver a revised opinion.
   (4)    With regard to the substance 2-butoxyethanol; ethylene glycol monobutyl ether; (CAS
          number 111-76-2), new scientific data has been made available for the hazard class
          ‘acute toxicity (inhalation)’ which suggests that the classification for this hazard class
          as recommended in the RAC opinion, which is based on older data, might not be
          appropriate. Therefore, this hazard class should not be modified in Annex VI to
          Regulation (EC) No 1272/2008 until RAC has had the opportunity to deliver a revised
          opinion based on the new information, while all other hazard classes covered by the
          RAC opinion should be included.
   (5)    Regulation (EC) No 1272/2008 should therefore be amended accordingly.
   (6)    Compliance with the new or updated harmonised classifications should not be required
          immediately as a certain period of time is necessary to allow suppliers to adapt the
          labelling and packaging of substances and mixtures to the new or revised
          classifications and to sell existing stocks subject to the pre-existing regulatory
          requirements. That period of time is also necessary to allow suppliers sufficient time to
          take the actions required to ensure continuing compliance with other legal
          requirements following the changes made under this Regulation. Such requirements
          may include those set out in point (f) of Article 22(1) of Regulation (EC) No
          1907/2006 of the European Parliament and of the Council4 or those set out in Article
          50 of Regulation (EU) No 528/2012 of the European Parliament and of the Council5.
   (7)    Suppliers should, however, have the possibility to apply the new classification,
          labelling and packaging provisions on a voluntary basis before the date of application
          of this Regulation. This is consistent with the approach taken under Article 61(2) of
          Regulation (EC) No 1272/2008,
   HAS ADOPTED THIS REGULATION:
                                                   Article 1
                            Amendments to Regulation (EC) No 1272/2008
   Table 3 of Part 3 of Annex VI to Regulation (EC) No 1272/2008 is amended as set out in the
   Annex to this Regulation.
   4
          Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006
          concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH),
          establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council
          Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council
          Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and
          2000/21/EC (OJ L 396, 30.12.2006, p. 1).
   5
          Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012
          concerning the making available on the market and use of biocidal products
          (OJ L 167, 27.6.2012, p. 1).
EN                                                     6                                                 EN
 ---pagebreak---                                                Article 2
                                   Entry into force and application
   This Regulation shall enter into force on the twentieth day following that of its publication in
   the Official Journal of the European Union.
   It shall apply from … [Publications Office, please insert a date corresponding to 18 months
   after the entry into force of this Regulation. The date should be the first day of the
   following month]
   By way of derogation from the second paragraph of this Article, substances and mixtures
   may, before [Publications Office, please insert specific date of application determined under
   the second paragraph] be classified, labelled and packaged in accordance with Regulation
   (EC) No 1272/2008 as amended by this Regulation.
   This Regulation shall be binding in its entirety and directly applicable in all Member States.
   Done at Brussels, 19.5.2020
                                                 For the Commission
                                                 The President
                                                 Ursula VON DER LEYEN
EN                                                 7                                                EN
 ---documentbreak---                             EUROPEAN
                            COMMISSION
                                                    Brussels, 19.5.2020
                                                    C(2020) 3151 final
                                                    ANNEX
                                           ANNEX
                                             to the
                        Commission Delegated Regulation (EU) ../..
   amending for the purposes of its adaptation to technical and scientific progress, Part 3
   of Annex VI to Regulation (EC) No 1272/2008 of the European Parliament and of the
       Council on classification, labelling and packaging of substances and mixtures
EN                                                                                          EN
 ---pagebreak---                                                                                         ANNEX
  In Annex VI to Regulation (EC) No 1272/2008, Table 3 of Part 3 is amended as follows:
              (1)      the following entries are inserted:
    Index No                  Chemical name                   EC No      CAS No               Classification                      Labelling                Specific       Notes
                                                                                                                                                            Conc.
                                                                                   Hazard Class and          Hazard    Pictogram,    Hazard     Suppl.   Limits, M-
                                                                                   Category Code(s)        statement     Signal     statement  Hazard    factors and
                                                                                                             Code(s) Word Code(s)    Code(s)  statement     ATE
                                                                                                                                               Code(s)
  ‘007-030-00-3   nitric acid …% [C ≤ 70 %]                 231-714-2 7697-37-2.   Ox. Liq. 3            H272        GHS03         H272       EUH071    Ox. Liq. 3;    B’
                                                                                   Acute Tox. 3          H331        GHS06         H331                 H272: C ≥ 65
                                                                                   Skin Corr. 1A         H314        GHS05         H314                 %
                                                                                                                     Dgr                                inhalation:
                                                                                                                                                        ATE = 2.65
                                                                                                                                                        mg/L
                                                                                                                                                        (vapours)
                                                                                                                                                        Skin Corr.
                                                                                                                                                        1A; H314: C
                                                                                                                                                        ≥ 20 %
                                                                                                                                                        Skin Corr. 1B;
                                                                                                                                                        H314: 5 % ≤
                                                                                                                                                        C <20 %
  ‘014-048-00-5   silicon carbide fibres (with diameter < 3 206-991-8  409-21-2    Carc. 1B              H350i       GHS08         H350i’
                  µm, length > 5 µm and aspect ratio ≥ 3:1)                                                          Dgr
                                                                       308076-74-6
  ‘014-049-00-0   trimethoxyvinylsilane;                    220-449-8  2768-02-7   Skin Sens. 1B         H317        GHS07         H317’
                  trimethoxy(vinyl)silane                                                                            Wng
  ‘014-050-00-6   tris(2-methoxyethoxy)vinylsilane;         213-934-0  1067-53-4   Repr. 1B              H360FD      GHS08         H360FD’
                                                                                                                     Dgr
                  6-(2-methoxyethoxy)-6-vinyl-2,5,7,10-
                  tetraoxa-6-silaundecane
EN                                                                                               1                                                                              EN
 ---pagebreak---                 Chemical name                               EC No         CAS No                   Classification                       Labelling                  Specific   Notes
    Index No                                                                                                                                                    Conc. Limits,
                                                                                      Hazard Class and            Hazard     Pictogram,    Hazard       Suppl.    M-factors
                                                                                      Category Code(s)           statement     Signal     statement    Hazard     and ATE
                                                                                                                  Code(s)  Word Code(s)    Code(s)    statement
                                                                                                                                                       Code(s)
  ‘016-098-00-3 dimethyl disulphide                      210-871-0     624-92-0       Flam. Liq. 2            H225         GHS02         H225                   inhalation:
                                                                                      Acute Tox. 3            H331         GHS06         H331                   ATE = 5
                                                                                      Acute Tox. 3            H301         GHS08         H301                   mg/L
                                                                                      STOT SE 3               H336         GHS09         H336                   (vapours)
                                                                                      STOT SE 1               H370 (upper  Dgr           H370                   oral: ATE =
                                                                                      Eye Irrit. 2            respiratory                (upper                 190 mg/kg bw
                                                                                      Skin Sens. 1            tract,                     respiratory
                                                                                      Aquatic Acute 1         inhalation)                tract,                 M=1
                                                                                      Aquatic Chronic 1       H319                       inhalation)            M=10’
                                                                                                              H317                       H319
                                                                                                              H400                       H317
                                                                                                              H410                       H410
  ‘029-024-00-X granulated copper;                       231-159-6     7440-50-8      Aquatic Chronic 2       H411         GHS09         H411’
                [particle length: from 0.9 mm to 6.0 mm;
                particle width: from 0.494 to 0.949 mm]
  ‘029-025-00-5 bis(N-hydroxy-N-                         239-703-4     312600-89-8    Flam. Sol. 1            H228         GHS02         H228                   oral: ATE =
                nitrosocyclohexylaminato-O,O')copper;                                 Acute Tox. 4            H302         GHS07         H302                   360 mg/kg bw
                                                                       15627-09-5     STOT RE 2               H373 (liver) GHS08         H373(liver)
                bis(N-cyclohexyl-diazenium-dioxy)-                                    Eye Dam. 1              H318         GHS05         H318                   M=1
                copper;                                                               Aquatic Acute 1         H400         GHS09         H410                   M=1’
                                                                                      Aquatic Chronic 1       H410         Dgr
                [Cu-HDO]
  ‘050-031-00-9 dioctyltin dilaurate; [1]                222-883-3 [1] 3648-18-8 [1]  Repr. 1B                H360D        GHS08         H360D
                                                         293-901-5 [2] 91648-39-4 [2] STOT RE 1               H372 (immune Dgr           H372
                stannane, dioctyl-, bis(coco acyloxy)                                                         system)                    (immune
                derivs. [2]                                                                                                              system)’
  ‘601-092-00-0 dibenzo[def,p]chrysene;                  205-886-4     191-30-0       Carc. 1B                H350         GHS08         H350                   Carc. 1B;
                                                                                      Muta. 2                 H341         Dgr           H341                   H350: C ≥
                dibenzo[a,l]pyrene                                                                                                                              0,001 %’
  ‘603-237-00-3 ipconazole (ISO);                        -             125225-28-7    Repr. 1B                H360D        GHS08         H360D
                                                                                      Acute Tox. 4            H302         GHS07         H302                   oral: ATE =
                (1RS,2SR,5RS;1RS,2SR,5SR)-2-(4-                        115850-69-6    STOT RE 2               H373 (eyes,  GHS09         H373 (eyes,            500 mg/kg bw
                chlorobenzyl)-5-isopropyl-1-(1H-1,2,4-                                Aquatic Chronic 1       skin, liver) Dgr           skin, liver)           M=100’
                triazol-1-ylmethyl)cyclopentanol                       115937-89-8                            H410                       H410
EN                                                                                                     2                                                                            EN
 ---pagebreak---                              Chemical name                 EC no      Cas no               Classification                        Labelling                 Specific    Notes
    Index No                                                                                                                                            Conc. Limits,
                                                                              Hazard Class and           Hazard       Pictogram,     Hazard     Suppl.    M-factors
                                                                              Category Code(s)          statement       Signal     statement   Hazard     and ATE
                                                                                                         Code(s)    Word Code(s)     Code(s)  statement
                                                                                                                                               Code(s)
  ‘603-238-00-9 bis(2-(2-methoxyethoxy)ethyl)ether;     205-594-7 143-24-8    Repr. 1B                H360FD        GHS08         H360FD’
                tetraglyme                                                                                          Dgr
  ‘603-239-00-4 paclobutrazol (ISO);                    -         76738-62-0  Repr. 2                 H361d         GHS08         H361d                 inhalation:
                                                                              Acute Tox. 4            H332          GHS07         H332                  ATE = 3.13
                (2RS,3RS)-1-(4-chlorophenyl)-4,4-                             Acute Tox. 4            H302          GHS09         H302                  mg/L (dusts or
                dimethyl-2-(1H-1,2,4-triazol-1-                               Eye Irrit. 2            H319          Wng           H319                  mists)
                yl)pentan-3-ol                                                Aquatic Acute 1         H400                        H410                  oral: ATE =
                                                                              Aquatic Chronic 1       H410                                              490 mg/kg bw
                                                                                                                                                        M=10
                                                                                                                                                        M=10’
  ‘603-240-00-X 2,2-bis(bromomethyl)propane-1,3-diol    221-967-7 3296-90-0   Carc. 1B                H350          GHS08         H350
                                                                              Muta. 1B                H340          Dgr           H340’
  ‘603-241-00-5 geraniol;                               203-377-1 106-24-1    Skin Sens. 1            H317          GHS07         H317’
                                                                                                                    Wng
                (2E)-3,7-dimethylocta-2,6-dien-1-ol
  ‘605-041-00-3 2-(4-tert-butylbenzyl)propionaldehyde   201-289-8 80-54-6     Repr. 1B                H360Fd        GHS08         H360Fd’
                                                                                                                    Dgr
  ‘607-738-00-8 MCPA-thioethyl (ISO);                   246-831-4 25319-90-8  Acute Tox. 4            H302          GHS07         H302                  oral: ATE =
                                                                              STOT RE. 2              H373 (liver)  GHS08         H373                  450 mg/kg bw
                S-ethyl (4-chloro-2-                                          Aquatic Acute 1         H400          GHS09         (liver)
                methylphenoxy)ethanethioate; S-ethyl 4-                       Aquatic Chronic 1       H410          Wng           H410                  M=10
                chloro-o-tolyloxythioacetate                                                                                                            M=10’
  ‘607-740-00-9 diisooctyl phthalate                    248-523-5 27554-26-3  Repr. 1B                H360FD        GHS08         H360FD’
                                                                                                                    Dgr
  ‘607-741-00-4 4-{[(6-chloropyridin-3-yl)methyl](2,2-  -         951659-40-8 Acute Tox. 4            H302          GHS07         H302                  oral: ATE =
                difluoroethyl)amino}furan-2(5H)-one;                          STOT RE 2               H373 (muscle) GHS08         H373                  500 mg/kg bw
                flupyradifurone                                               Aquatic Acute 1         H400          GHS09         (muscle)              M=10
                                                                              Aquatic Chronic 1       H410          Wng           H410                  M=10’
  ‘607-742-00-X thiencarbazone-methyl (ISO);            -         317815-83-1 Aquatic Acute 1         H400          GHS09         H410                  M=1000
                                                                              Aquatic Chronic 1       H410          Wng                                 M=1000’
                methyl 4-[(4,5-dihydro-3-methoxy-4-
                methyl-5-oxo-1H-1,2,4-triazol-1-
                yl)carbonylsulfamoyl]-5-
                methylthiophene-3-carboxylate
  ‘607-743-00-5 L-(+)-lactic acid;                      201-196-2 79-33-4     Skin Corr. 1C           H314          GHS05         H314       EUH071’
                                                                              Eye Dam. 1              H318          Dgr
                (2S)-2-hydroxypropanoic acid
EN                                                                                             3                                                                             EN
 ---pagebreak---                              Chemical name               EC no      Cas no                 Classification                       Labelling                 Specific    Notes
    Index No                                                                                                                                           Conc. Limits,
                                                                             Hazard Class and            Hazard      Pictogram,     Hazard     Suppl.    M-factors
                                                                             Category Code(s)           statement      Signal     statement   Hazard     and ATE
                                                                                                         Code(s)   Word Code(s)     Code(s)  statement
                                                                                                                                              Code(s)
  ‘607-744-00-0 2-methoxyethyl acrylate               221-499-3 3121-61-7    Flam. Liq. 3             H226         GHS02         H226       EUH071     inhalation:
                                                                             Muta. 2                  H341         GHS05         H341                  ATE = 2.7
                                                                             Repr. 1B                 H360FD       GHS06         H360FD                mg/L
                                                                             Acute Tox. 3             H331         GHS08         H331                  (vapours)
                                                                             Acute Tox. 4             H302         Dgr           H302                  oral: ATE =
                                                                             Skin Corr. 1C            H314                       H314                  404 mg/kg
                                                                             Eye Dam. 1               H318                       H317                  bw’
                                                                             Skin Sens. 1             H317
  ‘607-745-00-6 glyoxylic acid …%                     206-058-5 298-12-4     Eye Dam. 1               H318         GHS05         H318                                  B’
                                                                             Skin Sens. 1B            H317         GHS07         H317
                                                                                                                   Dgr
  ‘607-746-00-1 sodium N-(hydroxymethyl)glycinate;    274-357-8 70161-44-3   Carc. 1B                 H350         GHS08         H350                  inhalation:     8
                                                                             Muta. 2                  H341         GHS07         H341                  ATE = 3
                [formaldehyde released from sodium N-                        Acute Tox. 4             H332         Dgr           H332                  mg/L (dusts or  9’
                (hydroxymethyl)glycinate]                                    Acute Tox. 4             H302                       H302                  mists)
                                                                             STOT SE 3                H335                       H335                  oral: ATE =
                                                                             Skin Irrit. 2            H315                       H315                  1100 mg/kg
                                                                             Eye Irrit. 2             H319                       H319                  bw
                                                                             Skin Sens. 1             H317                       H317
  ‘611-181-00-6 potassium (oxido-NNO-                 -         66603-10-9   Flam. Sol. 1             H228         GHS02         H228                  oral: ATE =
                azoxy)cyclohexane;                                           Acute Tox. 3             H301         GHS06         H301                  136 mg/kg
                                                                             STOT RE 2                H373 (liver) GHS08         H373                  bw’
                cyclohexylhydroxydiazene 1-oxide,                            Skin Irrit. 2            H315         GHS05         (liver)
                potassium salt;                                              Eye Dam. 1               H318         GHS09         H315
                                                                             Aquatic Chronic 2        H411         Dgr           H318
                [K-HDO]                                                                                                          H411
  ‘612-294-00-3 mecetronium etilsulfate;              221-106-5 3006-10-8    Skin Corr. 1             H314         GHS05         H314       EUH071     M=100
                                                                             Eye Dam. 1               H318         GHS09         H410                  M=1000’
                N-ethyl-N,N-dimethylhexadecan-1-                             Aquatic Acute 1          H400         Dgr
                aminium ethyl sulfate;                                       Aquatic Chronic 1        H410
                mecetronium ethyl sulphate;
                [MES]
  ‘613-331-00-6 (2RS)-2-[4-(4-chlorophenoxy)-2-       -         1417782-03-6 Skin Sens. 1             H317         GHS07         H317                  M=1
                (trifluoromethyl)phenyl]-1-(1H-1,2,4-                        Aquatic Acute 1          H400         GHS09         H410                  M=1’
                triazol-1-yl)propan-2-ol;                                    Aquatic Chronic 1        H410         Wng
                mefentrifluconazole
EN                                                                                             4                                                                            EN
 ---pagebreak---                              Chemical name                  EC no     Cas no                Classification                      Labelling                Specific    Notes
    Index No                                                                                                                                          Conc. Limits,
                                                                                Hazard Class and          Hazard     Pictogram,   Hazard      Suppl.    M-factors
                                                                                Category Code(s)         statement     Signal    statement   Hazard     and ATE
                                                                                                          Code(s)  Word Code(s)   Code(s)   statement
                                                                                                                                             Code(s)
  ‘613-332-00-1 oxathiapiprolin (ISO);                   -         1003318-67-9 Aquatic Chronic 1      H410        GHS09         H410                 M=1’
                                                                                                                   Wng
                1-(4-{4-[5-(2,6-difluorophenyl)-4,5-
                dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-
                yl}piperidin-1-yl)-2-[5-methyl-3-
                (trifluoromethyl)-1H-pyrazol-1-
                yl]ethanone
  ‘613-333-00-7 pyrithione zinc; (T-4)-bis[1-(hydroxy-   236-671-3 13463-41-7   Repr. 1B               H360D       GHS08         H360D                inhalation:
                .kappa.O)pyridine-2(1H)-thionato-                               Acute Tox. 2           H330        GHS06         H330                 ATE = 0.14
                .kappa.S]zinc                                                   Acute Tox. 3           H301        GHS05         H301                 mg/L (dusts or
                                                                                STOT RE 1              H372        GHS09         H372                 mists)
                                                                                Eye Dam. 1             H318        Dgr           H318                 oral: ATE =
                                                                                Aquatic Acute 1        H400                      H410                 221 mg/kg bw
                                                                                Aquatic Chronic 1      H410                                           M=1000
                                                                                                                                                      M=10’
  ‘613-334-00-2 flurochloridone (ISO);                   262-661-3 61213-25-0   Repr. 1B               H360FD      GHS08         H360FD               oral: ATE =
                                                                                Acute Tox. 4           H302        GHS07         H302                 500 mg/kg bw
                3-chloro-4-(chloromethyl)-1-[3-                                 Skin Sens. 1           H317        GHS09         H317                 M=100
                (trifluoromethyl)phenyl]pyrrolidin-2-one                        Aquatic Acute 1        H400        Dgr           H410                 M=100’
                                                                                Aquatic Chronic 1      H410
  ‘613-335-00-8 4,5-dichloro-2-octyl-2H-isothiazol-3-    264-843-8 64359-81-5   Acute Tox. 2           H330        GHS06         H330      EUH071     inhalation:
                one; [DCOIT]                                                    Acute Tox. 4           H302        GHS05         H302                 ATE = 0.16
                                                                                Skin Corr. 1           H314        GHS09         H314                 mg/L (dusts or
                                                                                Eye Dam. 1             H318        Dgr           H317                 mists)
                                                                                Skin Sens. 1A          H317                      H410                 oral: ATE =
                                                                                Aquatic Acute 1        H400                                           567 mg/kg bw
                                                                                Aquatic Chronic 1      H410                                           Skin Irrit. 2;
                                                                                                                                                      H315: 0,025
                                                                                                                                                      %≤C<5%
                                                                                                                                                      Eye Irrit. 2;
                                                                                                                                                      H319: 0,025
                                                                                                                                                      %≤C<3%
                                                                                                                                                      Skin Sens.
                                                                                                                                                      1A; H317: C
                                                                                                                                                      ≥ 0,0015 %
                                                                                                                                                      M=100
                                                                                                                                                      M=100’
EN                                                                                              5                                                                          EN
 ---pagebreak---                              Chemical name                  EC no      Cas no              Classification                      Labelling                  Specific   Notes
    Index No                                                                                                                                           Conc. Limits,
                                                                               Hazard Class and           Hazard    Pictogram,    Hazard       Suppl.    M-factors
                                                                               Category Code(s)         statement     Signal     statement    Hazard     and ATE
                                                                                                          Code(s) Word Code(s)    Code(s)    statement
                                                                                                                                              Code(s)
  ‘613-336-00-3 2-methyl-1,2-benzothiazol-3(2H)-one;     -         2527-66-4   Acute Tox. 4           H312        GHS06         H312        EUH071     dermal: ATE
                                                                               Acute Tox. 3           H301        GHS05         H301                   = 1100 mg/kg
                [MBIT]                                                         Skin Corr. 1C          H314        GHS09         H314                   bw
                                                                               Eye Dam. 1             H318        Dgr           H317                   oral: ATE =
                                                                               Skin Sens. 1A          H317                      H410                   175 mg/kg bw
                                                                               Aquatic Acute 1        H400                                             Skin Sens.
                                                                               Aquatic Chronic 2      H411                                             1A; H317: C
                                                                                                                                                       ≥ 0,0015 %
                                                                                                                                                       M=1’
  ‘616-228-00-4 3-(difluoromethyl)-1-methyl-N-(3',4',5'- -         907204-31-3 Lact.                  H362        GHS09         H362                   M=1
                trifluorobiphenyl-2-yl)pyrazole-4-                             Aquatic Acute 1        H400        Wng           H410                   M=1’
                carboxamide;                                                   Aquatic Chronic 1      H410
                fluxapyroxad
  ‘616-230-00-5 N-(hydroxymethyl)acrylamide;             213-103-2 924-42-5    Carc. 1B               H350        GHS08         H350
                methylolacrylamide; [NMA]                                      Muta. 1B               H340        Dgr           H340
                                                                               STOT RE 1              H372                      H372
                                                                                                      (peripheral               (peripheral
                                                                                                      nervous                   nervous
                                                                                                      system)                   system)’
  ‘616-231-00-0 5-fluoro-1,3-dimethyl-N-[2-(4-           -         494793-67-8 Carc. 2                H351        GHS08         H351                   M=1
                methylpentan-2-yl)phenyl]-1H-pyrazole-                         Aquatic Acute 1        H400        GHS09         H410                   M=1’
                4-carboxamide; 2’-[(RS)-1,3-                                   Aquatic Chronic 1      H410        Wng
                dimethylbutyl]-5-fluoro-1,3-
                dimethylpyrazole-4-carboxanilide;
                penflufen
  ‘616-232-00-6 iprovalicarb (ISO);                      -         140923-17-7 Carc. 2                H351        GHS08         H351’
                                                                                                                  Wng
                isopropyl [(2S)-3-methyl-1-{[1-(4-
                methylphenyl)ethyl]amino}-1-oxobutan-
                2-yl]carbamate
  ‘616-233-00-1 silthiofam (ISO);                        -         175217-20-6 STOT RE 2              H373        GHS08         H373
                                                                               Aquatic Chronic 2      H411        GHS09         H411’
                N-allyl-4,5-dimethyl-2-                                                                           Wng
                (trimethylsilyl)thiophene-3-carboxamide
EN                                                                                             6                                                                           EN
 ---pagebreak---                                Chemical name                   EC no      Cas no              Classification                            Labelling                    Specific      Notes
    Index No                                                                                                                                                       Conc. Limits,
                                                                                   Hazard Class and          Hazard       Pictogram,      Hazard        Suppl.      M-factors
                                                                                   Category Code(s)         statement       Signal       statement     Hazard       and ATE
                                                                                                             Code(s)     Word Code(s)     Code(s)     statement
                                                                                                                                                       Code(s)
  ‘650-057-00-6   Margosa, ext. [cold-pressed oil of       283-644-7  84696-25-3   Aquatic Chronic 3     H412                            H412’
                  Azadirachta indica seeds without shells
                  extracted with super-critical carbon
                  dioxide]
              (2)     the entries corresponding to index numbers 007-004-00-1; 014-018-00-1; 015-134-00-5; 015-181-00-1; 050-021-00-4; 050-027-
                      00-7; 082-013-00-1; 603-014-00-0; 603-065-00-9; 605-019-00-3; 607-177-00-9; 607-256-00-8; 607-314-00-2; 609-041-00-4; 609-
                      064-00-X; 613-112-00-5; 613-115-00-1; 613-125-00-6; 613-202-00-4; 613-259-00-5; 616-014-00-0 and 617-006-00-X are
                      replaced by the following entries respectively:
       Index No                 Chemical name                 EC No     CAS No                 Classification                             Labelling                 Specific Conc.    Notes
                                                                                                                                                                      Limits, M-
                                                                                  Hazard Class and              Hazard       Pictogram,       Hazard       Suppl.    factors and
                                                                                   Category Code(s)           statement        Signal       statement     Hazard         ATE
                                                                                                                Code(s)    Word Code(s)       Code(s)    statement
                                                                                                                                                          Code(s)
                                                                                 Ox. Liq. 2                H272           GHS03            H272          EUH071     Ox. Liq. 2;
    ‘007-004-00-1 nitric acid …% [C > 70 %]                231-714-2 7697-37-2   Acute Tox. 1              H330           GHS06            H330                     H272: C ≥ 99 %      B’
                                                                                 Skin Corr. 1A             H314           GHS05            H314                     Ox. Liq. 3;
                                                                                                                          Dgr                                       H272: 70 % ≤ C
                                                                                                                                                                    < 99 %
                                                                                 Repr. 2                   H361f ***      GHS08            H361f ***
    ‘014-018-00-1 octamethylcyclotetrasiloxane;            209-136-7 556-67-2    Aquatic Chronic 1         H410           GHS09            H410                     M=10’
                  [D4]                                                                                                    Wng
                                                                                 Acute Tox. 4              H302           GHS07            H302                     oral: ATE =
    ‘015-134-00-5 pirimiphos-methyl (ISO);                 249-528-5 29232-93-7  STOT RE 1                 H372 (nervous  GHS08            H372                     1414 mg/kg bw
                  O-[2-(diethylamino)-6-methylpyrimidin-4-                       Aquatic Acute 1           system)        GHS09            (nervous
                  yl] O,O-dimethyl phosphorothioate                              Aquatic Chronic 1         H400           Dgr              system)
                                                                                                           H410                            H410                     M=1000
                                                                                                                                                                    M=1000’
EN                                                                                                7                                                                                         EN
 ---pagebreak---                                                                                                Classification                        Labelling               Specific Conc.
      Index No                Chemical name                    EC No     CAS No                                                                                Limits, M-     Notes
                                                                                   Hazard Class and             Hazard    Pictogram,     Hazard     Suppl.    factors and
                                                                                   Category Code(s)           statement     Signal      statement  Hazard         ATE
                                                                                                                Code(s) Word Code(s)     Code(s)  statement
                                                                                                                                                   Code(s)
                                                                                 Flam. Gas 1               H220         GHS02         H220                  inhalation:
   ‘015-181-00-1 phosphine                                  232-260-8 7803-51-2  Press. Gas                H330         GHS04         H330                  ATE = 10           U’
                                                                                 Acute Tox. 1              H314         GHS06         H314                  ppmV (gases)
                                                                                 Skin Corr. 1B             H400         GHS05         H400
                                                                                 Aquatic Acute 1                        GHS09
                                                                                                                        Dgr
                                                                                 Repr. 1B                  H360D        GHS08         H360D                 Repr. 1B; H360
   ‘050-021-00-4 dichlorodioctylstannane                    222-583-2 3542-36-7  Acute Tox. 2              H330         GHS06         H330                  D: C ≥ 0,03 %
                                                                                 STOT RE 1                 H372 **      Dgr           H372 **               inhalation: ATE
                                                                                 Aquatic Chronic 3         H412                       H412                  = 0.098 mg/L
                                                                                                                                                            (dusts or mists)’
                                                                                 Repr. 1B                  H360D        GHS08         H360D
   ‘050-027-00-7 2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8- 239-622-4 15571-58-1 STOT RE 1                 H372 (immune GHS09         H372
                 oxa-3,5-dithia-4-stannatetradecanoate;                          Aquatic Acute 1           system)      Dgr           (immune
                 [DOTE]                                                          Aquatic Chronic 1         H400                       system)
                                                                                                           H410                       H410‘
                                                                                 Repr. 1A                  H360FD       GHS08         H360FD                Repr. 1A;
   ‘082-013-00-1 lead powder; [particle diameter < 1 mm]    231-100-4 7439-92-1  Lact.                     H362         GHS09         H362                  H360D: C ≥
                                                                                 Aquatic Acute 1           H400         Dgr           H410                  0,03 %
                                                                                 Aquatic Chronic 1         H410                                             M=1
                                                                                                                                                            M=10’
                                                                                 Acute Tox. 4*             H332         GHS07         H332                  oral: ATE =
   ‘603-014-00-0 2-butoxyethanol;                           203-905-0 111-76-2   Acute Tox. 4              H302         Wng           H302                  1200 mg/kg
                 ethylene glycol monobutyl ether                                 Skin Irrit. 2             H315                       H315                  bw’
                                                                                 Eye Irrit. 2              H319                       H319
                                                                                 Carc. 1B                  H350         GHS08         H350                  dermal: ATE =
   ‘603-065-00-9 m-bis(2,3-epoxypropoxy)benzene;            202-987-5 101-90-6   Muta. 2                   H341         GHS06         H341                  300 mg/kg bw
                 resorcinol diglycidyl ether                                     Acute Tox. 3              H311         Dgr           H311                  oral: ATE =
                                                                                 Acute Tox. 4              H302                       H302                  500 mg/kg bw’
                                                                                 Skin Irrit. 2             H315                       H315
                                                                                 Eye Irrit. 2              H319                       H319
                                                                                 Skin Sens. 1              H317                       H317
                                                                                 Aquatic Chronic 3         H412                       H412
EN                                                                                                8                                                                                 EN
 ---pagebreak---                                                                                                 Classification                           Labelling               Specific Conc.
      Index No                 Chemical name                   EC No     CAS No                                                                                    Limits, M-    Notes
                                                                                   Hazard Class and             Hazard        Pictogram,    Hazard      Suppl.    factors and
                                                                                    Category Code(s)           statement        Signal     statement   Hazard         ATE
                                                                                                                Code(s)     Word Code(s)    Code(s)   statement
                                                                                                                                                       Code(s)
                                                                                  STOT RE 2                 H373            GHS08         H373                  M=100
   ‘607-177-00-9 tribenuron-methyl (ISO);                   401-190-1 101200-48-0 Skin Sens. 1              H317            GHS07         H317                  M=100’
                 methyl 2-[N-(4-methoxy-6-methyl-1,3,5-                           Aquatic Acute 1           H400            GHS09         H410
                 triazin-2-yl)-N-                                                 Aquatic Chronic 1         H410            Wng
                 methylcarbamoylsulfamoyl]benzoate
                                                                                  Acute Tox. 3              H331            GHS06         H331                  inhalation:
   ‘607-256-00-8 azoxystrobin (ISO);                        -         131860-33-8 Aquatic Acute 1           H400            GHS09         H410                  ATE = 0.7
                 methyl (E)-2-{2-[6-(2-                                           Aquatic Chronic 1         H410            Dgr                                 mg/L (dusts or
                 cyanophenoxy)pyrimidin-4-                                                                                                                      mists)
                 yloxy]phenyl}-3-methoxyacrylate                                                                                                                M=10
                                                                                                                                                                M=10’
                                                                                  Aquatic Acute 1           H400            GHS09         H410                  M=1
   ‘607-314-00-2 ethofumesate (ISO);                        247-525-3 26225-79-6  Aquatic Chronic 1         H410            Wng                                 M=1’
                 (RS)-2-ethoxy-2,3-dihydro-3,3-
                 dimethylbenzofuran-5-yl
                 methanesulfonate
                                                                                  Acute Tox. 3 *            H331            GHS06         H331                  dermal: ATE =
   ‘609-041-00-4 2,4-dinitrophenol                          200-087-7 51-28-5     Acute Tox. 3              H311            GHS08         H311                  300 mg/kg bw
                                                                                  Acute Tox. 2              H300            GHS09         H300                  oral: ATE = 30
                                                                                  STOT RE 1                 H372            Dgr           H372                  mg/kg bw’
                                                                                  Aquatic Acute 1           H400                          H400
                                                                                  Repr. 2                   H361d           GHS08         H361d                 M=10
   ‘609-064-00-X mesotrione (ISO);                          -         104206-82-8 STOT RE 2                 H373 (eyes,     GHS09         H373 (eyes,           M=10’
                 2-[4-(methylsulfonyl)-2-nitrobenzoyl]-1,3-                       Aquatic Acute 1           nervous system) Wng           nervous
                 cyclohexanedione                                                 Aquatic Chronic 1         H400                          system)
                                                                                                            H410                          H410
                                                                                  Acute Tox. 2              H330            GHS06         H330        EUH071    inhalation: ATE
   ‘613-112-00-5 octhilinone (ISO);                         247-761-7 26530-20-1  Acute Tox. 3              H311            GHS05         H311                  = 0.27 mg/L
                 2-octyl-2H-isothiazol-3-one; [OIT]                               Acute Tox. 3              H301            GHS09         H301                  (dusts or mists)
                                                                                  Skin Corr. 1              H314            Dgr           H314                  dermal: ATE =
                                                                                  Eye Dam. 1                H318                          H317                  311 mg/kg bw
                                                                                  Skin Sens. 1A             H317                          H410                  oral: ATE =
                                                                                  Aquatic Acute 1           H400                                                125 mg/kg bw
                                                                                  Aquatic Chronic 1         H410                                                Skin Sens. 1A;
                                                                                                                                                                H317: C ≥
                                                                                                                                                                0,0015 %
                                                                                                                                                                M=100
                                                                                                                                                                M=100’
EN                                                                                                 9                                                                                   EN
 ---pagebreak---                                                                                                Classification                              Labelling                 Specific Conc.
      Index No                Chemical name                   EC No     CAS No                                                                                        Limits, M-     Notes
                                                                                  Hazard Class and              Hazard          Pictogram,     Hazard       Suppl.    factors and
                                                                                   Category Code(s)           statement           Signal      statement    Hazard         ATE
                                                                                                                Code(s)       Word Code(s)     Code(s)    statement
                                                                                                                                                           Code(s)
                                                                                 Repr. 2                   H361d              GHS08         H361d                   oral: ATE =
   ‘613-115-00-1 hymexazol (ISO);                          233-000-6 10004-44-1  Acute Tox. 4              H302               GHS07         H302                    1600 mg/kg
                 3-hydroxy-5-methylisoxazole                                     Eye Dam. 1                H318               GHS05         H318                    bw’
                                                                                 Skin Sens. 1              H317               GHS09         H317
                                                                                 Aquatic Chronic 2         H411               Dgr           H411
                                                                                 Aquatic Acute 1           H400               GHS09         H410                    M=1
   ‘613-125-00-6 hexythiazox (ISO);                        -         78587-05-0  Aquatic Chronic 1         H410               Wng                                   M=1’
                 trans-5-(4-chlorophenyl)-N-cyclohexyl-4-
                 methyl-2-oxo-3-thiazolidine-carboxamide
                                                                                 Carc. 2                   H351               GHS08         H351                    M=1’
   ‘613-202-00-4 pymetrozine (ISO);                        -         123312-89-0 Repr. 2                   H361fd             GHS09         H361fd
                 (E)-4,5-dihydro-6-methyl-4-(3-                                  Aquatic Chronic 1         H410               Wng           H410
                 pyridylmethyleneamino)-1,2,4-triazin-
                 3(2H)-one
                                                                                 Carc. 2                   H351               GHS08         H351                    inhalation: ATE
   ‘613-259-00-5 imiprothrin (ISO);                        428-790-6 72963-72-5  Acute Tox. 4              H332               GHS07         H332                    = 1.4 mg/L
                 reaction mass of: [2,4-dioxo-(2-propyn-1-                       Acute Tox. 4              H302               GHS09         H302                    (dusts or mists)
                 yl)imidazolidin-3-yl]methyl(1R)-cis-                            STOT SE 2                 H371 (nervous      Wng           H371                    oral: ATE =
                 chrysanthemate; [2,4-dioxo-(2-propyn-1-                         Aquatic Acute 1           system; oral,                    (nervous                550 mg/kg bw
                 yl)imidazolidin-3-yl]methyl(1R)-trans-                          Aquatic Chronic 1         inhalation)                      system; oral,
                 chrysanthemate                                                                            H400                             inhalation)             M=10
                                                                                                           H410                             H410                    M=10 ‘
                                                                                 Carc. 1B                  H350               GHS08         H350                    dermal: ATE =
   ‘616-014-00-0 butanone oxime; ethyl methyl ketoxime; 202-496-6    96-29-7     Acute Tox. 4              H312               GHS06         H312                    1100 mg/kg bw
                 ethyl methyl ketone oxime                                       Acute Tox. 3              H301               GHS05         H301                    oral: ATE =
                                                                                 STOT SE 3                 H336               Dgr           H336                    100 mg/kg bw’
                                                                                 STOT SE 1                 H370 (upper                      H370 (upper
                                                                                 STOT RE 2                 respiratory tract)               respiratory
                                                                                 Skin Irrit. 2             H373 (blood                      tract)
                                                                                 Eye Dam. 1                system)                          H373 (blood
                                                                                 Skin Sens. 1              H315                             system)
                                                                                                           H318                             H315
                                                                                                           H317                             H318
                                                                                                                                            H317
                                                                                 Org. Perox. F             H242               GHS02         H242
   ‘617-006-00-X bis(α,α-dimethylbenzyl) peroxide          201-279-3 80-43-3     Repr. 1B                  H360D              GHS08         H360D
                                                                                 Skin Irrit. 2             H315               GHS07         H315
                                                                                 Eye Irrit. 2              H319               GHS09         H319
                                                                                 Aquatic Chronic 2         H411               Dgr           H411’
EN                                                                                               10                                                                                        EN
 ---pagebreak---    (3) the entries corresponding to index numbers 601-064-00-8 and 607-693-00-4 are deleted.
EN                                                              11                           EN